Skip to search formSkip to main contentSkip to account menu

Levo-methamphetamine

Known as: l-desoxyephedrine, levometamfetamine, LEVMETAMFETAMINE 
National Institutes of Health

Related topics

Related topics

1 relation
Dextromethamphetamine/Levomethamphetamine:MRto:Pt:Urine:Qn

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®.
This final rule adopts the interim final rule, with a correction to spelling of the manufacturer's name that was published in the… 
2016
2016
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
This final rule adopts, without change, the interim final rule that was published in the Federal Register on October 27, 2015… 
Review
2013
Review
2013
Exploiting the Power of Stereochemistry in Drugs: An Overview of Racemic and Enantiopure Drugs
Abstract: Stereochemistry is one of the essential dimensions in pharmacology as it dictates how enantiomers interact with… 
2010
2010
Schedules of controlled substances; table of excluded nonnarcotic products: nasal decongestant inhalers manufactured by Classic Pharmaceuticals, LLC. Final rule.
Under this Final Rule, the Drug Enforcement Administration (DEA) is updating the Table of Excluded Nonnarcotic Products found in… 
2004
2004
PROCEDE POUR LA PREPARATION DE LA R-(-)-N-α-DIMETHYLPHENETHYLAMINE (LEVMETAMFETAMINE) OU DE LA S-(+)-N-α-DIMETHYLPHENETHYLAMINE (METHAMPHETAMINE), A PARTIR DE LA D-EPHEDRINE OU L-EPHEDRINE…
L’invention concerne un procede destine a la synthese de la R-(-)-N-α-dimethylphenethylamine (levmetamfetamine, formule I), ou de… 
Highly Cited
2001
Highly Cited
2001
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.
In view of conflicting data in the literature regarding the enzyme(s) responsible for metabolism of selegiline, a drug used in… 
1997
1997
Desmethylselegiline, a Metabolite of Selegiline, Is an Irreversible Inhibitor of Monoamine Oxidase Type B in Humans
Selegiline, an irreversible and selective inhibitor of monoamine oxidase type B (MAO‐B), is metabolized into desmethylselegiline… 
1961
1961
Absorption of tritiated d-desoxyephedrine in sustained-release dosage forms.
Randomly labeled H3-d-desoxyephedrine was rigorously purified, and the stability of the label was established both in vitro and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)